Evan David Seigerman, BMO managing director, joins ‘Fast Money’ to discuss Novo sinking on its obesity drug data. Source link
Trending
- Max Purcell admits doping violation: U.S. Open doubles champion enters provisional suspension
- Suspect in UnitedHealth executive’s killing pleads not guilty to murder, terrorism charges
- Here are our top 10 things to watch in the stock market Monday
- Biden commutes dozens of death row sentences to life without parole
- Wall Street’s unwanted S&P 500 stocks for 2025 may face declines
- Container Store seeks bankruptcy protection
- Meta went all in on AI in 2024. The pressure builds in 2025
- MicroStrategy rides ‘red sweep’ to 477% gain in 2024, top tech stock
Money
The ‘Fast Money’ traders talk the market’s reaction to news the Fed plans two or…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailFast MoneyLoretta Mester,…
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via EmailGuest trader Michael…
The final trades of the day with CNBC’s Melissa Lee and the Fast Money traders.…
Ben Emmon, FedWatch Advisors, joins ‘Fast Money’ to talk movement in bond yields after the…
The ‘Fast Money’ traders talk T. Rowe Price’s recent call that the 10-year yields could…
